W. JeffreyPettyMD

PubMed

• Durable response to amivantamab in treatment refractory NSCLC harboring EGFR and complex MET mutations: A case report.
  Chance Bloomer, Wei Zhang, William Petty, Schmalz, L.> ;Lung Cancer. 2023 Dec 1
• 12 citations
  High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.
  Jeffrey Bogart, Xiaofei Wang, Gregory Masters, Junheng Gao, Ritsuko Komaki, Laurie E Gaspar, John Heymach, James Bonner, Charles Kuzma, Saiama Waqar, William Petty, Th...> ;Journal of Clinical Oncology. 2023 May 1
• Team-Based Hospice Referrals: A Potential Quality Metric for Lung Cancer in the Immunotherapy Era.
  Thomas W Lycan Jr, Alyssa Buckenheimer, Jimmy Ruiz, Gregory Russell, Andy Shipe Dothard, Tamjeed Ahmed, Stefan Grant, Carl Grey, William J Petty> ;The American Journal of Hospice & Palliative Care. 2023 Jan 1
• 4 citations
  Long-Term Outcomes From a Phase 2 Trial of Radiofrequency Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer
  C. Steber, R.T. Hughes, James J. Urbanic, Hollins P. Clark, W. Jeffrey Petty, A. William Blackstock, Michael Farris> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Sep 1
• 7 citations
  Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer.
  David Kozono, Thomas E. Stinchcombe, Joseph K. Salama, Jeffrey A. Bogart, W. Jeffrey Petty, Michael J. Guarino, Lyudmila Bazhenova, James M. Larner, Jared Weiss, Thoma...> ;Lung Cancer. 2021 Jul 21
• 22 citations
  Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer.
  Antao Chang, Liang Liu, Justin M. Ashby, Dan Wu, Yanan Chen, Stacey S O'Neill, Shan Huang, Juan Wang, Guanwen Wang, Dongmei Cheng, Xiaoming Tan, William J. Petty, Bori...> ;Cancer Research. 2021 Jun 15
• 7 citations
  Phase I Study of Muscadine Grape Extract for Patients With Advanced Cancer.
  Rhonda L. Bitting, Janet A. Tooze, Scott Isom, W. Jeffrey Petty, Stefan C. Grant, Rodwige J. Desnoyers, Alexandra Thomas, Christopher Y. Thomas, Angela Tatiana Alistar...> ;American Journal of Clinical Oncology. 2021 Jun 1
• 11 citations
  An overview of lurbinectedin as a new second-line treatment option for small cell lung cancer.
  S. Patel, William J. Petty, Jacob Sands> ;Therapeutic Advances in Medical Oncology. 2021 May 29
• 1 citations
  Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer Fr...
  Jing Su, Lynn S. Huang, Ryan T. Barnard, Graham E. Parks, James O. Cappellari, Christina Bellinger, Travis Dotson, Lou Craddock, Bharat Prakash, Jonathan T. Hovda, Hol...> ;Frontiers in Oncology. 2021 Apr 16
• 12 citations
  Unmet Care Needs and Financial Hardship in Patients With Metastatic Non–Small-Cell Lung Cancer on Immunotherapy or Chemoimmunotherapy in Clinical Practice
  Laurie E. McLouth, Chandylen L Nightingale, Beverly J. Levine, Jessica L. Burris, Jean A. McDougall, Thomas Lycan, Jennifer Gabbard, Jimmy Ruiz, Michael Farris, Arthur...> ;JCO Oncology Practice. 2021 Feb 4
• 25 citations
  SMARCA4 mutations in KRAS-mutant lung adenocarcinoma: a multi-cohort analysis
  Liang Liu, Tamjeed Ahmed, William J. Petty, Stefan C. Grant, Jimmy Ruiz, Thomas Lycan, Umit Topaloglu, Ping Chieh Chou, Lance D. Miller, Gregory A. Hawkins, Martha A. ...> ;Molecular Oncology. 2021 Feb 1
• Adverse Event Reporting at Professional Conferences: We Need Better Standards and Bigger Posters.
  Thomas Lycan, W. Jeffrey Petty> ;Journal of Thoracic Oncology. 2020 Sep 1
• 17 citations
  Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer
  Tamjeed Ahmed, Thomas Lycan, Andy Dothard, Paul Ehrlichman, Jimmy Ruiz, Michael Farris, Umit Topaloglu, Beverly J. Levine, Stefan C. Grant, Heidi D. Klepin, W. Jeffrey...> ;Clinical Lung Cancer. 2020 Jul 1
• 27 citations
  Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical Practice.
  Laurie E. McLouth, Thomas Lycan, Beverly J. Levine, Jennifer Gabbard, Jimmy Ruiz, Michael Farris, Stefan C. Grant, Nicholas M. Pajewski, Kathryn E. Weaver, W. Jeffrey ...> ;Clinical Lung Cancer. 2020 May 1
• 8 citations
  The OaSiS trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer.
  Kristie L. Foley, David P. Miller, Kathryn E. Weaver, Erin L. Sutfin, W. Jeffrey Petty, Christina Bellinger, John G. Spangler, Rebecca J. Stone, Donna Lawler, Whitney ...> ;Contemporary Clinical Trials. 2020 Feb 20
• 113 citations
  An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
  Liu Yang, William Crowe, Lulu Wang, Yong Lu, W. Jeffrey Petty, Amyn A. Habib, Dawen Zhao> ;Nature Communications. 2019 Nov 8
• 51 citations
  Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries
  C.M. Lanier, R.T. Hughes, Tamjeed Ahmed, M.C. LeCompte, Adrianna H. Masters, William J. Petty, Jimmy Ruiz, Pierre L. Triozzi, Jing Su, Stacy O'Neill, Kuonosuke Watabe,...> ;Neuro-Oncology Practice. 2019 Sep 20
• 12 citations
  Lung Cancer Patient and Caregiver Health Vulnerabilities and Interest in Health Promotion Interventions: An Exploratory Study.
  Chandylen L Nightingale, Laurie E. Steffen, Janet A. Tooze, William J. Petty, Suzanne C. Danhauer, Hoda Badr, Kathryn E. Weaver> ;Global Advances in Health and Medicine. 2019 Jul 17
• 18 citations
  Limited-Stage Small Cell Lung Cancer: Is Prophylactic Cranial Irradiation Necessary?
  Michael Farris, W.H. Wheless, Ryan T. Hughes, Michael H. Soike, Adrianna H. Masters, Corbin A. Helis, Michael D. Chan, Christina K. Cramer, Jimmy Ruiz, Thomas Lycan, W...> ;Practical Radiation Oncology. 2019 Jul 2
• 10 citations
  Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial.
  Ammoren E. Dohm, Jing Su, Emory R. McTyre, James M. Taylor, Lance D. Miller, W. Jeffrey Petty, Fei Xing, Hui-Wen Lo, Linda J. Metheny-Barlow, Stacey S O'Neill, Christi...> ;The International Journal of Biological Markers. 2019 Mar 10
• 40 citations
  Pleural Effusion Aspirate for Use in 3D Lung Cancer Modeling and Chemotherapy Screening
  Andrea Mazzocchi, Mahesh Devarasetty, Samuel Herberg, William J. Petty, Frank C. Marini, Lance D. Miller, Gregory L. Kucera, David K. Dukes, Jimmy Ruiz, Aleksander Ska...> ;ACS Biomaterials Science & Engineering. 2019 Mar 8
• 44 citations
  Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.
  Jimmy Ruiz, Antonius A. Miller, Janet A. Tooze, Sandrine Crane, William J. Petty, Ajeet Gajra, Heidi D. Klepin> ;Journal of Geriatric Oncology. 2019 Jan 1
• 4 citations
  Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial).
  Travis Dotson, Christina Bellinger, Jing Su, Kris Hansen, Graham E. Parks, James O. Cappellari, Lou Craddock, Hollins P. Clark, Clifford Howard, W. Jeffrey Petty, Bhar...> ;Lung Cancer. 2019 Jan 1
• 27 citations
  Circulating immune biomarkers as predictors of the response to pembrolizumab and weekly low dose carboplatin and paclitaxel in NSCLC and poor PS: An interim analysis.
  Marcelo Bonomi, Tamjeed Ahmed, Safoa Addo, Mitra Kooshki, Dario Palmieri, Beverly J. Levine, Jimmy Ruiz, Stefan C. Grant, William J. Petty, Pierre L. Triozzi> ;Oncology Letters. 2018 Nov 19
• 8 citations
  Cure of Oligometastatic Classic Biphasic Pulmonary Blastoma Using Aggressive Tri-modality Treatment: Case Series and Review of the Literature
  Jennifer A. Lewis, William J. Petty, James J. Urbanic, Eric D Bernstein, Tamjeed Ahmed> ;Cureus. 2018 Nov 13
• Join now to see all